Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FSSAI issues detailed guidelines on recall of food products

      FSSAI issues detailed guidelines on recall of food products

      Ruby Khatun Khatun2 Dec 2017 9:15 AM IST
      New Delhi: Food safety regulator FSSAI asked companies to put in place a proper plan to recall food products from markets if found unsafe and also...
      Cipla gets WHO approval to sell TB preventing drug in HIV patients

      Cipla gets WHO approval to sell TB preventing drug in HIV patients

      Ruby Khatun Khatun1 Dec 2017 2:40 PM IST
      New Delhi: Drug major Cipla said it has received approval from the World Health Organisation (WHO) for Q-TIB, a combination drug indicated to help...
      Piramal acquires Digeplex from Shreya Lifesciences

      Piramal acquires Digeplex from Shreya Lifesciences

      Ruby Khatun Khatun1 Dec 2017 11:00 AM IST
      MUMBAI: Piramal Enterprises acquired the Digeplex and the associated brands from Shreya Lifesciences for an undisclosed sum to expand its consumer...
      Securities class action lawsuit served on Dr Reddys in US

      Securities class action lawsuit served on Dr Reddys in US

      Ruby Khatun Khatun1 Dec 2017 10:41 AM IST
      New Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
      ICMR in collaboration with Zydus Cadila launches diagnostic kits to detect livestock diseases

      ICMR in collaboration with Zydus Cadila launches diagnostic kits to detect livestock diseases

      Ruby Khatun Khatun1 Dec 2017 10:15 AM IST
      New Delhi: The Indian Council of Medical Research (ICMR) launched diagnostic kits to detect neglected infectious diseases in livestock.The kits have...
      GSK submits US regulatory application for single-dose Tafenoquine for Plasmodium vivax malaria

      GSK submits US regulatory application for single-dose Tafenoquine for Plasmodium vivax malaria

      Ruby Khatun Khatun1 Dec 2017 10:02 AM IST
      London, UK, Geneva, Switzerland: GSK and Medicines for Malaria Venture (MMV) announced the submission of a new drug application (NDA) by GSK to the...
      UK announces pharma investment, aims to boost productivity

      UK announces pharma investment, aims to boost productivity

      Ruby Khatun Khatun1 Dec 2017 9:45 AM IST
      LONDON: Britain has announced a major investment by US drug-maker Merck, as the UK government unveils plans to boost productivity after Brexit.The...
      Merck KGaA, Pfizer

      Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial

      Ruby Khatun Khatun1 Dec 2017 9:30 AM IST
      FRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
      Skeptical Democrats to quiz Trump health pick on drug prices

      Skeptical Democrats to quiz Trump health pick on drug prices

      Ruby Khatun Khatun1 Dec 2017 9:15 AM IST
      WASHINGTON: Skeptical Democratic senators are getting a chance to question President Donald Trump's pick for health secretary about what he'll do...
      Sanofi dengue vaccine may worsen disease, company takes 120 million dollars hit

      Sanofi dengue vaccine may worsen disease, company takes 120 million dollars hit

      Ruby Khatun Khatun30 Nov 2017 2:09 PM IST
      PARIS: Use of Sanofi's dengue vaccine, the world's first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it...
      Zydus Cadila gets USFDA nod for blood pressure treatment drug

      Zydus Cadila gets USFDA nod for blood pressure treatment drug

      Ruby Khatun Khatun30 Nov 2017 10:45 AM IST
      New Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
      Shalby fixes price band between Rs 245-248 per share for IPO

      Shalby fixes price band between Rs 245-248 per share for IPO

      Ruby Khatun Khatun30 Nov 2017 10:30 AM IST
      Mumbai: Ahmedabad-based multi-specialty hospital chain Shalby said it has fixed the price band between Rs 245 to Rs 248 per equity share for its...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok